MinireviewEscaping Cell Death: Survival Proteins in Cancer☆
References (190)
- et al.
Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
Cell
(1996) - et al.
FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to CD95 (Fas/APO-1) death-inducing signaling complex
Cell
(1996) - et al.
Cytochromec
Cell
(1997) - et al.
Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochromec
Cell
(1997) - et al.
Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1 and staurosporine-induced cell death
J. Biol. Chem.
(1996) - et al.
bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation
Cell
(1989) - et al.
bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
Cell
(1991) - et al.
Bcl-xL overexpression restricts heat-induced apoptosis and influences hsp70, bcl-2, and Bax protein levels in FL5.12 cells
Biochem. Biophys. Res. Commun.
(1997) - et al.
Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex
J. Biol. Chem.
(1998) - et al.
Diva, a Bcl-2 homologue that binds directly to Apaf-1 and induces BH3-independent cell death
J. Biol. Chem.
(1998)
Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms
Blood
(1991)
Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: A British National Lymphoma Investigation Study
Blood
(1996)
Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)
Blood
(1996)
BCL-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: An Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory study
Blood
(1998)
High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
Blood
(1993)
Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse
Blood
(1998)
Absence of prognostic significance of bcl-2 immunopositivity in non- small cell lung cancer: Analysis of 427 cases
Hum. Pathol.
(1997)
Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer
J. Urol.
(1996)
Bcl-2 expression in malignant melanoma and its prognostic significance
Eur. J. Surg. Oncol.
(1996)
Bcl-2 oncoprotein expression and apoptosis in neuroblastoma
J. Pediatr. Surg.
(1995)
Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
Blood
(1998)
Death receptors: Signaling and Modulation
Science
(1998)
Mitochondria and apoptosis
Science
(1998)
A matter of life and cell death
Science
(1998)
Caspases: Enemies within
Science
(1998)
The Bcl-2 protein family: Arbiters of cell survival
Science
(1998)
The inhibitors of apoptosis (IAPs) and their emerging role in cancer
Oncogene
(1998)
Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity
EMBO J.
(1992)
Role of human heat shock protein hsp70 in protection against stress-induced apoptosis
Mol. Cell. Biol.
(1997)
Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases
EMBO J.
(1998)
HSP27 is a mediator of confluence-dependent resistance to cell death induced by anticancer drugs
Cancer Res.
(1997)
Involvement of the bcl-2 gene in human follicular lymphoma
Science
(1985)
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Nature
(1988)
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
Nature
(1990)
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Nature
(1990)
Apoptotic cell death induced by c-myc is inhibited by bcl-2
Nature
(1992)
bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs
Cancer Res.
(1992)
Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity
Oncogene
(1993)
Effect of bcl-2 on Fas antigen-mediated cell death
J. Immunol.
(1993)
Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2
Oncogene
(1995)
The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type
J. Virol.
(1997)
BCl-2 family: regulators of cell death
Annu. Rev. Immunol.
(1998)
Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins
Oncogene
(1998)
Bcl-2 family proteins
Oncogene
(1998)
Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms
EMBO J.
(1999)
Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum, and mitochondrial membrane
Cancer Res.
(1994)
Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types
EMBO J.
(1996)
The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis
Science
(1997)
Prevention of apoptosis by Bcl-2: Release of cytochromec
Science
(1997)
Bcl-xL
Nature
(1997)
Cited by (0)
- ☆
Martin, S. J.
- 1
To whom reprint requests should be addressed. Fax: 45-35257721. E-mail:[email protected].
Copyright © 1999 Academic Press. All rights reserved.